Mydriatic responses to sympathomimetic amines in patients treated with L-dopa.
D000317:Adrenergic alpha-Antagonists; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007022:Hypotension / Q000209:etiology; D009184:Mydriatics / Q000494:pharmacology*; D009638:Norepinephrine; D010300:Parkinson Disease / Q000188:drug therapy; D010656:Phenylephrine / Q000494:pharmacology*; D010919:Placebos; D011680:Pupil / Q000187:drug effects*; D014439:Tyramine / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D009184:Mydriatics; D010919:Placebos; D010656:Phenylephrine; D004295:Dihydroxyphenylalanine; D009638:Norepinephrine; D014439:Tyramine